Anne E Cress
Overview
Explore the profile of Anne E Cress including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen W, Epshtein Y, Vagts C, Cress A, Jacobson J
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076507
Integrin β4 (ITGB4) mediates lung endothelial cell (EC) inflammation attenuated by simvastatin, an HMG CoA-reductase inhibitor. The cytoplasmic domain of ITGB4 is predicted to bind kindlin-2. Kindlin-2 expression is mediated...
2.
Clements A, Casillas A, Flores C, Liou H, Toth R, Chauhan S, et al.
Cancer Immunol Res
. 2025 Feb;
PMID: 39982419
Immune checkpoint inhibitors (ICIs) have changed the treatment paradigm for many cancers but have not shown benefit in prostate cancer (PCa). Chronic inflammation contributes to the immunosuppressive prostate tumor microenvironment...
3.
Clements A, Casillas A, Flores C, Liou H, Toth R, Chauhan S, et al.
bioRxiv
. 2024 Nov;
PMID: 39484473
Immunotherapy has changed the treatment paradigm for many types of cancer, but immune checkpoint inhibitors (ICIs) have not shown benefit in prostate cancer (PCa). Chronic inflammation contributes to the immunosuppressive...
4.
Paxson A, Chang L, Gard J, Harryman W, Nelson C, Salmon S, et al.
Front Cell Dev Biol
. 2023 Dec;
11:1285372.
PMID: 38046670
In 2023, approximately 288,300 new diagnoses of prostate cancer will occur, with 34,700 disease-related deaths. Death from prostate cancer is associated with metastasis, enabled by progression of tumor phenotypes and...
5.
Marr K, Gard J, Harryman W, Keeswood E, Paxson A, Wolgemuth C, et al.
Biophys J
. 2023 Sep;
122(21):4194-4206.
PMID: 37766428
Bladder, colon, gastric, prostate, and uterine cancers originate in organs surrounded by laminin-coated smooth muscle. In human prostate cancer, tumors that are organ confined, without extracapsular extension through muscle, have...
6.
Jensen C, Clements A, Liou H, Ball L, Bethard J, Langlais P, et al.
J Cell Biol
. 2023 Apr;
222(6).
PMID: 37042842
Distinguishing key factors that drive the switch from indolent to invasive disease will make a significant impact on guiding the treatment of prostate cancer (PCa) patients. Here, we identify a...
7.
Marr K, Ignatenko N, Warfel N, Batai K, Cress A, Pollock G, et al.
Front Oncol
. 2023 Feb;
12:1083150.
PMID: 36727054
The advent of perpetuating living organoids derived from patient tissue is a promising avenue for cancer research but is limited by difficulties with precise characterization. In this brief communication, we...
8.
Mascarenhas J, Song J, A Gaber A, Jacobson J, Cress A, Camp S, et al.
Cell Physiol Biochem
. 2022 Jul;
56(4):329-339.
PMID: 35856787
Background/aims: Increase in vascular permeability is a cardinal feature of all inflammatory diseases and represents an imbalance in vascular contractile forces and barrier-restorative forces, both of which are highly dependent...
9.
Ryniawec J, Coope M, Loertscher E, Bageerathan V, De Oliveira Pessoa D, Warfel N, et al.
Diagnostics (Basel)
. 2022 Mar;
12(3).
PMID: 35328229
The microenvironment of solid tumors is dynamic and frequently contains pockets of low oxygen levels (hypoxia) surrounded by oxygenated tissue. Indeed, a compromised vasculature is a hallmark of the tumor...
10.
Harryman W, Marr K, Nagle R, Cress A
Front Cell Dev Biol
. 2022 Mar;
10:837585.
PMID: 35300411
Muscle-invasive lethal carcinomas traverse into and through this specialized biophysical and growth factor enriched microenvironment. We will highlight cancers that originate in organs surrounded by smooth muscle, which presents a...